Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf with or without Sirolimus in Kidney Transplant
NCT01363752Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2011
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands
- Countries
- 17
01
Overview
Phase 4, randomised, open-label trial of tacrolimus + Wuzhi capsule in kidney transplant rejection (2 arms), sponsored by Astellas Pharma. Primary endpoint: Glomerular Filtration Rate estimated by iohexol clearance at 52 weeks. Started Mar 2011; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01363752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363752.